EA200200320A1 - ПОЛИМОРФЫ N-МЕТИЛ-N-(3-{3-[2-ТИЕНИЛКАРБОНИЛ]ПИРАЗОЛ[1,5-α]ПИРИМИДИН-7-ИЛ}ФЕНИЛ)АЦЕТАМИДА И ОТНОСЯЩИЕСЯ К НИМ КОМПОЗИЦИИ И СПОСОБЫ - Google Patents

ПОЛИМОРФЫ N-МЕТИЛ-N-(3-{3-[2-ТИЕНИЛКАРБОНИЛ]ПИРАЗОЛ[1,5-α]ПИРИМИДИН-7-ИЛ}ФЕНИЛ)АЦЕТАМИДА И ОТНОСЯЩИЕСЯ К НИМ КОМПОЗИЦИИ И СПОСОБЫ

Info

Publication number
EA200200320A1
EA200200320A1 EA200200320A EA200200320A EA200200320A1 EA 200200320 A1 EA200200320 A1 EA 200200320A1 EA 200200320 A EA200200320 A EA 200200320A EA 200200320 A EA200200320 A EA 200200320A EA 200200320 A1 EA200200320 A1 EA 200200320A1
Authority
EA
Eurasian Patent Office
Prior art keywords
pyrimidin
acetamide
phenyl
methyl
methods
Prior art date
Application number
EA200200320A
Other languages
English (en)
Other versions
EA004706B1 (ru
Inventor
Вилльям Дж. Тил
Патрик Б. О'Доннелл
Original Assignee
Ньюрокрайн Байосайенсиз Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ньюрокрайн Байосайенсиз Инк. filed Critical Ньюрокрайн Байосайенсиз Инк.
Publication of EA200200320A1 publication Critical patent/EA200200320A1/ru
Publication of EA004706B1 publication Critical patent/EA004706B1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Описываются полиформы N-метил-N-(3-{3-[2-тиенилкарбонил]пиразол[1,5-α]пиримидин-7-ил}фенил)ацетамида (соединение 1) и их применение в качестве седативно-снотворного, транквилизирующего, противосудорожного и расслабляющего скелетные мышцы агента. Раскрываются как процессы получения соединений, а также относящиеся к ним композиции и способы, в особенности, что касается лечения бессонницы. Предоставляется полиморф формы I, обладающий исключительной физической и тепловой стабильностью. Описывается полиморф формы II.Международная заявка была опубликована вместе с отчетом о международном поиске.
EA200200320A 1999-09-02 2000-09-01 ПОЛИМОРФЫ N-МЕТИЛ-N-(3-{3-[2-ТИЕНИЛКАРБОНИЛ]ПИРАЗОЛ [1,5-α]ПИРИМИДИН-7-ИЛ}ФЕНИЛ)АЦЕТАМИДА И ОТНОСЯЩИЕСЯ К НИМ КОМПОЗИЦИИ И СПОСОБЫ EA004706B1 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US38952499A 1999-09-02 1999-09-02
US42162099A 1999-10-19 1999-10-19
PCT/US2000/024051 WO2001015700A1 (en) 1999-09-02 2000-09-01 POLYMORPHS OF N-METHYL-N-(3-{3-[2-THIENYLCARBONYL]-PYRAZOL-[1,5-α]-PYRIMIDIN -7-YL }PHENYL )ACETAMIDE AND COMPOSITIONS AND METHODS RELATED THERETO

Publications (2)

Publication Number Publication Date
EA200200320A1 true EA200200320A1 (ru) 2002-08-29
EA004706B1 EA004706B1 (ru) 2004-06-24

Family

ID=27012737

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200200320A EA004706B1 (ru) 1999-09-02 2000-09-01 ПОЛИМОРФЫ N-МЕТИЛ-N-(3-{3-[2-ТИЕНИЛКАРБОНИЛ]ПИРАЗОЛ [1,5-α]ПИРИМИДИН-7-ИЛ}ФЕНИЛ)АЦЕТАМИДА И ОТНОСЯЩИЕСЯ К НИМ КОМПОЗИЦИИ И СПОСОБЫ

Country Status (26)

Country Link
EP (2) EP1477169A1 (ru)
JP (1) JP4592241B2 (ru)
KR (1) KR20020035585A (ru)
CN (2) CN1331865C (ru)
AP (1) AP1631A (ru)
AT (1) ATE269082T1 (ru)
AU (2) AU769856B2 (ru)
BR (1) BR0014459A (ru)
CA (1) CA2382588C (ru)
CZ (1) CZ2002783A3 (ru)
DE (1) DE60011638T2 (ru)
DK (1) DK1214075T3 (ru)
EA (1) EA004706B1 (ru)
ES (1) ES2222920T3 (ru)
HK (1) HK1047407B (ru)
HU (1) HUP0202698A3 (ru)
IL (2) IL148242A0 (ru)
MX (1) MXPA02002314A (ru)
NO (1) NO322752B1 (ru)
NZ (1) NZ517298A (ru)
OA (1) OA12200A (ru)
PL (1) PL353362A1 (ru)
PT (1) PT1214075E (ru)
SK (1) SK2782002A3 (ru)
TR (1) TR200200534T2 (ru)
WO (1) WO2001015700A1 (ru)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60309332T2 (de) 2002-08-26 2007-05-24 Neurocrine Biosciences, Inc., San Diego POLYMORPH VON N-METHYL-N-(3- 3-i2-THIENYLCARBONYLö-PYRAZOL-i1,5-ALPHAö-PYRIMIDIN-7-YL PHENYL)ACETAMID UND ZUSAMMENSETZUNGEN SOWIE VERFAHREN HIERZU
WO2004110454A1 (ja) * 2003-06-13 2004-12-23 Ishihara Sangyo Kaisha, Ltd. アデノシンＡ2ａ受容体アゴニストの投与が必要な疾患を治療又は予防するための組成物
US7371906B2 (en) * 2004-08-24 2008-05-13 Eastman Kodak Company Process for photo-oxidative stability improvements
EP1956021A1 (en) * 2006-10-11 2008-08-13 Ferrer Internacional, S.A. Process for the manufacture of a crystalline pyrazolo[1,5-a]pyrimidine compound
EP1918290A1 (en) * 2006-10-11 2008-05-07 Ferrer Internacional, S.A. Polymorph B of N-{2-Fluoro-5-[3-(thiophene-2-carbonyl)-pyrazolo[1,5-a] pyrimidin-7-yl]-phenyl}-N-methyl-acetamide
CN101177427B (zh) * 2006-11-09 2011-07-20 中国人民解放军军事医学科学院放射与辐射医学研究所 一种用于催眠的化合物的多晶型α和溶剂化物,其制备方法及含该物质的组合物
WO2010109480A2 (en) * 2009-03-24 2010-09-30 Glenmark Generics Limited Processes for the preparation of indiplon and intermediates thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4654347A (en) * 1983-06-23 1987-03-31 American Cyanamid Company Aryl and heteroaryl[[7-(3-disubstituted amino)phenyl]pyrazolo[1,5-a]pyrimidin-3-yl]methanones
US4626538A (en) * 1983-06-23 1986-12-02 American Cyanamid Company [7-(3-disubstituted amino)phenyl]pyrazolo[1,5-a]pyrimidines
NZ208554A (en) * 1983-06-23 1987-06-30 American Cyanamid Co (aryl and heteroaryl)-(7-(aryl and heteroaryl)-pyrazolo (1,5-a) pyrimidin-3-yl)-methanone derivatives and pharmaceutical compositions
US4521422A (en) * 1983-06-23 1985-06-04 American Cyanamid Company Aryl and heteroaryl[7-(aryl and heteroaryl)pyrazolo[1,5-a]pyrimidin-3-yl]methanones
DE3689294T2 (de) * 1985-05-13 1994-06-09 American Cyanamid Co [7-(3-Disubstituierte Amino)phenyl]pyrazolo[1,5-a]-pyrimidine.
US5421422A (en) * 1993-11-19 1995-06-06 Boretec Inc Roller cutter mount for tunneling machine

Also Published As

Publication number Publication date
CZ2002783A3 (cs) 2004-01-14
EA004706B1 (ru) 2004-06-24
AU2004201356A1 (en) 2004-04-29
AU6949100A (en) 2001-03-26
EP1477169A1 (en) 2004-11-17
HK1047407A1 (en) 2003-02-21
NO322752B1 (no) 2006-12-04
SK2782002A3 (en) 2003-04-01
WO2001015700A9 (en) 2002-09-12
DK1214075T3 (da) 2004-10-25
IL148242A0 (en) 2002-09-12
WO2001015700A1 (en) 2001-03-08
HK1047407B (zh) 2004-12-24
CN1198824C (zh) 2005-04-27
NO20021041L (no) 2002-04-03
CA2382588C (en) 2008-11-25
AU769856B2 (en) 2004-02-05
ATE269082T1 (de) 2004-07-15
EP1214075A1 (en) 2002-06-19
AP2002002428A0 (en) 2002-03-31
CN1374866A (zh) 2002-10-16
CN1331865C (zh) 2007-08-15
OA12200A (en) 2006-05-09
HUP0202698A2 (hu) 2002-12-28
JP4592241B2 (ja) 2010-12-01
AP1631A (en) 2006-07-12
PL353362A1 (en) 2003-11-17
IL148242A (en) 2006-12-10
NO20021041D0 (no) 2002-03-01
HUP0202698A3 (en) 2004-12-28
EP1214075A4 (en) 2003-05-02
PT1214075E (pt) 2004-11-30
CN1680376A (zh) 2005-10-12
DE60011638D1 (de) 2004-07-22
TR200200534T2 (tr) 2002-06-21
KR20020035585A (ko) 2002-05-11
MXPA02002314A (es) 2002-08-12
DE60011638T2 (de) 2004-10-21
EP1214075B1 (en) 2004-06-16
JP2003508440A (ja) 2003-03-04
ES2222920T3 (es) 2005-02-16
NZ517298A (en) 2004-01-30
BR0014459A (pt) 2002-07-16
CA2382588A1 (en) 2001-03-08

Similar Documents

Publication Publication Date Title
TNSN05058A1 (en) Novel polymorph of n-methyl-n-(3-{3-[2-thienylcarbonyl]-pyrazol-[1,5-alpha]-pyrimidin-7-yl}phenyl) acetamide and compositions and methods related thereto
Sternbach The benzodiazepine story
KR870004034A (ko) N-치환-N-[3-(1,2,4-트리아졸로[4,3-b]피리다진-6-일)페닐]알칸아미드, 카바메이트 및 우레아 화합물과 그 제조방법 사용방법 및 조성물
DE60100750D1 (de) NEUE KRISTALLINE FORM VON N-[4-[2-(2-AMINO-4,7-DIHYDRO-4-OXO-3H-PYRROLO[2,3-d]-PYRIMIDIN-5-YL)ETHYL]BENZOYL]-L-GLUTAMINSÄURE UND VERFAHREN FÜR IHRE HERSTELLUNG
YU61595A (sh) Nova naftilna jedinjenja, njihovi intermedijeri farmaceutske kompozicije, i postupci za dobijanje tih jedinjenja
FI802404A (fi) Foerfarande foer framstaellning av terapeutiskt aktiva heterocykliska foereningar
KR970042543A (ko) N-[3-(3-시아노피라졸로[1,5-a]피리미딘-7-일)페닐]-N-에틸아세트아미드의 개선된 합성방법
EA200200320A1 (ru) ПОЛИМОРФЫ N-МЕТИЛ-N-(3-{3-[2-ТИЕНИЛКАРБОНИЛ]ПИРАЗОЛ[1,5-α]ПИРИМИДИН-7-ИЛ}ФЕНИЛ)АЦЕТАМИДА И ОТНОСЯЩИЕСЯ К НИМ КОМПОЗИЦИИ И СПОСОБЫ
NZ199796A (en) T-butyl 5,6-dihydro-6-oxo(or thio)-4h-imidazo(1,5-a)(1,4)benzo(or thiophenyl)diazepine-3-carboxylate derivatives
DK1344768T3 (da) Syntese af substituerede pyrazolopyrimidiner
MXPA03001048A (es) Polimorfos de zaleplon y metodos para la preparacion de los mismos.
MXPA04003278A (es) Derivados de 5-metoxi-8-aril-?1,2,4?triazolo?1,5-a?piridina como antagonistas del receptor de adenosina.
ATE42292T1 (de) Imidazo(1,2-c)pyrimidine und ihre salze, verfahren zu ihrer herstellung, ihre anwendung als arzneimittel und diese enthaltende zubereitungen.
ATE289583T1 (de) Stereoisomere von propyl-isopropylacetamid, verfahren zu deren herstellung sowie diese enthaltende pharmazeutische zubereitungen
US3894025A (en) 1-Piperazino-6-phenyl-4H-s-triazolo{8 4,3-a{9 {8 1,4{9 -benzodiazepine compounds
ATE94878T1 (de) Imidazobenzodiazepine und ihre saeureadditionssalze, verfahren und zwischenprodukte zu ihrer herstellung, ihre verwendung als arzneimittel und diese enthaltende zubereitungen.
HUP0301500A2 (hu) Eljárás imidazo [1,2-c][2,3]benzodiazepin-származékok és köztitermékeik előállítására
ATE227289T1 (de) Verfahren zur herstellung von azyklischen nukleosiden
DK161077C (da) Analogifremgangsmaade til fremstilling af 1,7-dihydropyrrol oe3,4-eaa-oe1,4aadiazepin-2(3h)-on-derivater eller farmaceutisk acceptable syreadditionssalte deraf
TH17047A (th) อนุพันธ์ของ n-ซับสทิทิวเทด อะซาไบไซโคลเฮพเทน, การเตรียมและการใช้ประโยชน์ของสารเหล่านี้

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM RU